On The Pen With Dave Knapp
Durata totale:
25 h 33 min
Compounded Retatrutide? What the Judge Said
On The Pen With Dave Knapp
30:01
Retatrutide Weight Loss: How Much At Each Dose
On The Pen With Dave Knapp
50:24
Mounjaro vs. New Obesity Drugs: Why Wave-007 Is Stealing the Spotlight
On The Pen With Dave Knapp
34:00
GLP-1: New Metrics, New Molecules, New Prices
On The Pen With Dave Knapp
29:39
Novo Nordisk Amycretin Shocker + Semaglutide Flopper
On The Pen With Dave Knapp
36:28
Wegovy GLP-1 Price Novo Blinks First
On The Pen With Dave Knapp
32:02
GLP-1 State of the Union
On The Pen With Dave Knapp
45:44
Lower Cost Zepbound and Wegovy? TrumpRX Announcement Incoming
On The Pen With Dave Knapp
45:58
Eli Lilly Earnings Call Recap: NEW GLP-1 GIP Peptide Announced!
On The Pen With Dave Knapp
23:55
Retatrutide + Tirzepatide Grey Market Clampdown + 1 Billion GLP-1 Pills Incoming
On The Pen With Dave Knapp
29:41
HLTH 2025: Obesity Care Superstar Interviews
On The Pen With Dave Knapp
49:48
TRUMP: Ozempic Will Soon be $150 in the US! Meet the Reporter Who Made Him Say It!
On The Pen With Dave Knapp
29:33
Wegovy and Ozempic Users: FDA's Scathing Report on Major Novo Factory
On The Pen With Dave Knapp
27:44
Retatrutide News That Could Change Everything for GLP-1 Compounds
On The Pen With Dave Knapp
40:26
Sobriety Meets Weight Loss: The Ethan Suplee Interview
On The Pen With Dave Knapp
38:01
Mounjaro Hair Loss + NFL Lineman Discovers Power in Personalized Medicine
On The Pen With Dave Knapp
70:55
Stopping Zepbound and Maintaining with Revita
On The Pen With Dave Knapp
42:24
GLP-1 Treatment and Advocacy with Dr. Leslie Golden
On The Pen With Dave Knapp
77:07
Pfizer GLP-1 Play Worth $7.3B + Compound Tirzepatide Update
On The Pen With Dave Knapp
34:13
GLP-1 Weight Loss, Why It's About So Much More for Patients
On The Pen With Dave Knapp
50:03
Compound GLP-1 Legislation + FDA Warning Letter to HIMS
On The Pen With Dave Knapp
44:20
FDA CRACKDOWN on Compounded GLP-1s | Novo’s Gut Hack & Lilly’s One-Shot Cure
On The Pen With Dave Knapp
39:02
Is Wegovy Better Than Zepbound? Plus the First Obesity GLP-1 Generic is Here!
On The Pen With Dave Knapp
26:01
Zepbound Compound Lawsuit Update: Eli Lilly Vs Mochi
On The Pen With Dave Knapp
66:26
Eli Lilly VS Mochi Update + Big Lilly Orforglipron Secret Revealed
On The Pen With Dave Knapp
36:00
Ozempic Price Cut + New Obesity Pill Data
On The Pen With Dave Knapp
34:01
GLP-1 Microdosing For Weight Loss: Noom CEO Explains Their New Program
On The Pen With Dave Knapp
42:22
Eli Lilly Earnings Call Recap: Stock Tanks on Weight Loss Pill Miss
On The Pen With Dave Knapp
59:23
Novo Nordisk Blames Compound Semaglutide on Slower Sales
On The Pen With Dave Knapp
24:38
No Compounded Retatrutide Says the FDA + Tons of GLP-1 News
On The Pen With Dave Knapp
41:14
LEAKED TRUMP DOCUMENT: Medicare to Cover Zepbound and Wegovy for Obesity
On The Pen With Dave Knapp
26:46
Retatrutide Drops are Crazy // OTP TWD 7.29.25
On The Pen With Dave Knapp
33:17
Compound GLP-1 Injections : You Won't Believe What The Obesity Society is Saying
On The Pen With Dave Knapp
24:04
Connecticut Making Ozempic!? Meet The Mastermind
On The Pen With Dave Knapp
26:22
SHOCKING: How GLP-1 Protects the Heart Beyond Weight Loss // OTP TWD 7.25.25
On The Pen With Dave Knapp
20:20
BREAKING: Insurance Approving Mounjaro Over Zepbound!? What is Going On!?
On The Pen With Dave Knapp
17:34
Behind the Scenes of the Obesity Drug Battle | Obesity Action Coalition President Interview
On The Pen With Dave Knapp
35:23
Unlocking Zepbound Insurance Coverage + More GLP-1 Good News // otp twd 7.1.25
On The Pen With Dave Knapp
33:37
Lilly Could Lose Their Tirzepatide Patent! Plus ADA Coverage // OTP TWD 06.24.25
On The Pen With Dave Knapp
26:52
Faces of The Fight: The Jamie Selzler Story
On The Pen With Dave Knapp
57:43
